Nav: Home

Modulating a hormonal pathway improves social function in 2 clinical trials of adults and children with autism spectrum disorder

May 01, 2019

Results from two clinical trials reveal that modulating the hormone vasopressin's biological pathway safely enhanced social functioning in 223 adult men and 30 children with autism spectrum disorder (ASD). The findings indicate drugs that target vasopressin could potentially help address social and behavioral deficits across diverse subpopulations of patients with the condition. Although there are several medications approved to treat ASD, they have negative side effects and do not address core symptoms such as problems with social communication and repetitive behaviors. However, an increasing body of research in mice has showed that vasopressin - a peptide that regulates social behavior in mammals - could be a promising target for new therapies. In the first study, Federico Bolognani and colleagues conducted a randomized, placebo-controlled phase 2 clinical trial where they evaluated the efficacy of balovaptan - an oral drug candidate that inhibits the receptor for vasopressin - in 223 adult men with moderate or severe ASD. The researchers split the patients into four groups and administered one of three doses of balovaptan or placebo daily for 12 weeks. They did not observe any improvements in the trial's primary endpoint as measured by the Social Responsiveness Scale or SRS (a scale that assesses social impairment in individuals with ASD). However, Bolognani et al. observed that the two patient groups that received higher doses (totaling 116 participants) displayed improvements in a second scale measuring socialization, adaptive behavior and daily living skills compared to the cohort treated with placebo (75 patients), findings that met study's secondary endpoint. Importantly, balovaptan was also well-tolerated and did not raise safety concerns, indicating it could help treat ASD in a patient group that has seen few benefits from previous trials. Taking a different approach, Karen Parker and colleagues investigated whether administering vasopressin to children with ASD could counteract social deficits. They intranasally delivered either a large dose of vasopressin or a placebo to 30 children (25 male, five female) between the ages of six and 12 for four weeks. Based on reports from the children's parents, the authors found the 17 treated children showed enhanced social behaviors as measured by the SRS (the study's primary endpoint) compared to the 13 placebo-treated individuals. Furthermore, the treated children displayed improvements in social communication as evaluated by clinicians. They were also better able to interpret the emotional and mental states of others and recognize faces in laboratory tests. Vasopressin treatment also reduced other ASD symptoms such as anxiety and was well-tolerated by the subjects.

American Association for the Advancement of Science

Related Autism Spectrum Disorder Articles:

Investigation of inherited mutations in Autism Spectrum Disorder
Scientists from the Institute for Stem Cell Science and Regenerative Medicine (inStem) and collaborators investigated inherited mutations in Autism Spectrum Disorder.
Using virtual reality to help individuals with autism spectrum disorder
Novel interventions using virtual reality to aid individuals with autism spectrum disorder (ASD) handle common scenarios may include helping youngsters navigate air travel.
Studies of autism spectrum disorder reveal new avenues of neuroscience research
Advances in the study of cognitive disorders, including Autism Spectrum Disorder (ASD), may pave the way for future treatments.
Autism spectrum disorder risk linked to insufficient placental steroid
A study led by Children's National Hospital and presented during Neuroscience 2019 finds that loss of allopregnanolone, a key hormone supplied by the placenta, leads to long-term structural alterations of the cerebellum -- a brain region essential for smooth motor coordination, balance and social cognition -- and increases the risk of developing autism.
The Lancet Psychiatry: Compensatory strategies to disguise autism spectrum disorder may delay diagnosis
For the first time, compensatory strategies used by people with autism have been investigated and collated in a qualitative study using an online survey of 136 adults, published in The Lancet Psychiatry journal.
Exercise fine-tunes brain's connections, eases autism spectrum disorder in mouse model
A mouse model of autism has revealed how exercise changes the structure of the brain by eliminating the excess connections between neurons characteristic of autism spectrum disorder (ASD).
New approaches to study the genetics of autism spectrum disorder may lead to new therapies
Autism spectrum disorder (ASD) is highly variable disorder, both in its presentation and in its genetics -- hundreds of risk genes have been identified.
A step toward better understanding brain anatomy of autism spectrum disorder
A new study, led by researchers at McGill University's Faculty of Medicine and the Douglas Mental Health University Institute, set out to settle some of the discrepancies related to brain anatomy and ASD, employing a large dataset to obtain their findings.
Modulating a hormonal pathway improves social function in 2 clinical trials of adults and children with autism spectrum disorder
Results from two clinical trials reveal that modulating the hormone vasopressin's biological pathway safely enhanced social functioning in 223 adult men and 30 children with autism spectrum disorder (ASD).
Does wearable behavioral intervention improve social behavior in kids with autism spectrum disorder?
This randomized clinical trial of 71 children with autism spectrum disorder (ASD) tested a wearable behavioral intervention deployed on Google Glass and worn by children at home to reinforce facial engagement and emotion recognition to improve social behavior.
More Autism Spectrum Disorder News and Autism Spectrum Disorder Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at